<header id=045820>
Published Date: 2011-12-02 05:40:08 EST
Subject: PRO/EDR> Hepatitis C - China (03): background
Archive Number: 20111202.3509
</header>
<body id=045820>
HEPATITIS C - CHINA (03): BACKGROUND
************************************

A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: Wed 30 Nov 2011
Source: GIDEON (Global Infectious Disease & Epidemiology Network)
[edited]
http://www.gideononline.com


Hepatitis C virus infection in China
------------------------------------
The following background information on hepatitis C virus (HCV)
infection in China has been abstracted from the Gideon database
(http://www.GideonOnline.com) and the Gideon e-book series. [1,2]

Prevalence surveys (antibody and/or viral RNA):
General population
------------------
- Hepatitis C accounted for 8 percent of acute hepatitis cases in
Nanchong (2004 publication) to 18.1 percent of acute hepatitis in the
Beijing area (1995 to 2000).
- 4.07 percent of the general population in 1997; 3.0 percent in 1999
(estimates)
- 0.58 percent nationwide (6 regions, 2009 publication).
- 0.15 percent of adults in Liangshan Prefecture, Sichuan Province
(2011 publication).
- 8.2 percent of rural adults in Shanxi = 96 27.7 percent of former
commercial blood/plasma donors (2003).
- 0.9 percent of persons in Anyang (2006 to 2008).
- 0.5 percent of normal subjects (and 5.0 percent of liver disease
patients) in Nanjing (1997 publication).
- 31.0 percent of persons in central Tibet (2001).
- 1.1 percent to 2.7 percent of the general population of Beijing.
- 9.6 percent of elderly adults in Linxian (rural Henan) (2000).

Blood donors
------------
- 8.68 percent of blood donors.
- 12.87 percent prior to 1998 (15.78 percent during 1994 to 1995) and
1.71 percent after 1998 (analysis of 265 studies, 2011 publication).
- 0 percent to 1.1 percent of volunteer blood donors (1997).
- 29.19 percent of non-remunerated blood donors in Shaoxing (2007
publication).
- 30 percent of professional blood donors in Hebei and Inner
Mongolia.
- 1.5 percent to 3 percent in professional blood donors from Liaoning
and Anhui (1993 publication).
- 0.49 percent of blood donors in Chongqing (2008 publication).
- 0.53 percent of blood donors in Chengdu (2006 to 2007).
- 0.335 percent of voluntary blood donors in Guangzhou (2004 to
2007).
- 12.7 percent of former commercial blood/plasma donors in rural
Shanxi Province (2004).

Injecting drug users (IDU)
--------------------------
- As of 2011, an estimated 10 million injecting drug users worldwide
are seropositive toward hepatitis C virus -- including 1.6 million in
China.
- 32.35 percent of IDU (15 cities, 2011 publication).
- 4.0 percent of IDU (2010 publication).
- 66.97 percent of IDU (range 11.43 percent in Shaanxi to 90.77
percent in Hubei) vs. 18.37 percent of non-injecting drug users
(literature review, 2009).
- 61.4 percent of IDU in China, with highest rates in Hubei, Yunnan,
Guangxi, Hunan, and Xinjiang (2008 publication).
- 71.0 percent of IDU in Sichuan (2002); 67.49 percent in Guangzhou.
- 69.7 percent of IDU in Wuhan (2006 publication).
- 63.2 percent of IDU in Dongguan, Guangdong (2008).
- 71.6 percent of IDU in Guangdong (2010 publication).
- 94.3 percent of IDU on methadone maintenance, in Wuhan (2008
publication).
- 69.0 percent of Chinese and 48.1 percent of Burmese IDU in the
China-Burma border region (2011 publication).
- 56.9 percent of HIV-positive IDU (2003 publication).

HIV-positive patients
---------------------
- 78.6 percent of HIV-positive former blood donors (Hubei, 2008
publication).
- 76.4 percent of HIV-positive patients vs. 2.5 percent of
HIV-negative individuals (Shanxi Province, 2010 publication).
- 41.83 percent of HIV-positive patients (2007 to 2008).
- 59.0 percent of HIV-positive patients (Shanxi, Zhejiang, Yunnan, and
Xinjiang, 2011 publication).
- 9.6 percent of HIV-positive children receiving ART (2009
publication).
- 19.4 percent of HIV-positive patients receiving AART (Beijing, 2005
to 2007).
- 83.6 percent of AIDS patients were found to be co-infected with
hepatitis C, 2.3 percent singly co-infected with hepatitis B, and 5.5
percent co-infected with HIV/HCV/HBV; 8.6 percent were infected with
HIV only. (Zhengzhou, publication 2006).

Men who have sex with men (MSM)
-------------------------------
- 0.4 percent of MSM in 2004; 5.2 percent in 2006 (Beijing).
- 0.8 percent of MSM in Beijing (2005 to 2006).
- 0.4 percent of MSM in Beijing (2008 publication).
- 0.7 percent of MSM in Jiangsu (2006 to 2007).
- 0 percent of MSM in Taizhou city, Zhejiang province (2008
publication).

Commercial sex workers/clients
------------------------------
- 6.8 percent of CSW in Kunming, Yunnan (2008 publication).
- 8.7 percent of male clients of CSW in Sichuan (2010 publication).

Patients with hepatitis/liver disease
-------------------------------------
- 14 percent to 27 percent of patients with chronic hepatitis.
- 16 percent of hepatitis B carriers.
- 43 percent of patients with cirrhosis.
- 39 percent of patients with hepatocellular carcinoma.

Hemodialysis patients
---------------------
- 54 percent of hemodialysis patients and 6 percent of commercial
blood donors
- 96 rates somewhat higher among carriers of Hepatitis GB-C (Beijing,
1996).
- 41 percent of hemodialysis patients (meta-analysis, 2009
publication).
- 17.2 percent of hemodialysis patients in Zhejiang (2009
publication).

Others
------
- 1.72 percent of patients with oral lichen planus (2010
publication).
- 1.30 percent of subjects with thyroid autoantibodies vs. 0.53
percent of a control group (2011 publication).
- Primary liver cancer, one of the principal sequelae of hepatitis C,
is the 2nd most common malignancy in China, responsible for 360 000
incident cases, and 350 000 deaths per year. Mortality rates of liver
cancer were 17.6 and 7.3 per 100 000 for males and females during 1973
to 1975; 29.0 and 11.2 per 100 000 during 1990 to 1992; and 37.55 and
4.45 per 100 000 during 2004 to 2005.

References
----------
1. Berger SA: Infectious Diseases of China, 2011. 635 pp, 253 graphs,
3049 references. Gideon e-books
http://www.gideononline.com/ebooks/country/infectious-diseases-of-china/.
2. Berger SA: Hepatitis C: Global Status, 2011. 164 pp, 160 graphs,
1500 references. Gideon e-books
http://www.gideononline.com/ebooks/disease/hepatitis-c-global-status/.

--
Communicated by:
Dr Steve Berger
Geographic Medicine
Tel Aviv Medical Center
Israel
<mberger@post.tau.ac.il>

[ProMED-mail thanks Steve Berger for compiling these data. He has
indicated that the primary references can be obtained from him on
request. - Mod.CP]
See Also
Hepatitis C - China (02): (AH) unsterilized needles 20111130.3493
Hepatitis C - China: (AH), unsterilised needles 20111129.3484
2010
----
Hepatitis C, nosocomial - China (02): (IMAR) 20100519.1657
Hepatitis C, nosocomial - China (AH), RFI 20100107.0070
2007
----
Hepatitis C - China: blood products recall (02) 20070127.0361
Hepatitis C - China: blood products recall 20070125.0337
.................................................cp/mj/jw
</body>
